Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00698984 · ClinicalTrials.gov registry record · NA
Investigation of the Effect of BONISTEIN(R) Bone Blend on Bone Mineral Density/Content and Biomarkers of Bone Health
A NA study, sponsored by dsm-firmenich Switzerland.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT00698984 is a NA study that has completed, run by dsm-firmenich Switzerland. The registered enrollment target is 70 participants.
The verdict
NCT00698984, a NA study, has completed, sponsored by dsm-firmenich Switzerland.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain information about the effect of a combination of genistein, PUFAs, vitamin K and D (BONISTEIN(R) bone blend) on bone health, determined as bone mass density/content and bone biomarkers after 6-months treatment in 70 healthy postmenopausal women. In addition, safety and tolerability will be investigated.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT BONISTEIN(R) bone blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00698984
The ClinicalTrials.gov registry entry for NCT00698984 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is dsm-firmenich Switzerland, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00698984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00698984 about?
NCT00698984 is a clinical study titled "Investigation of the Effect of BONISTEIN(R) Bone Blend on Bone Mineral Density/Content and Biomarkers of Bone Health". The purpose of this study is to obtain information about the effect of a combination of genistein, PUFAs, vitamin K and D (BONISTEIN(R) bone blend) on bone health, determined as bone mass density/content and bone biomarkers after 6-months treatment in 70 healthy postmenopausal women. In addition, sa...
What is the current status of trial NCT00698984?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2007-01. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00698984?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), BONISTEIN(R) bone blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00698984?
This trial is sponsored by dsm-firmenich Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.